Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Pauline Du Rusquec"'
Autor:
Ségolène Hescot, Julien Masliah-Planchon, Pauline du Rusquec, Célia Dupain, Maud Kamal, Vincent Servois, Ivan Bieche
Publikováno v:
European Thyroid Journal, Vol 11, Iss 5, Pp 1-3 (2023)
Medullary thyroid carcinoma (MTC) is a rare but aggressive thyroid tumor, with 25% of hereditary and 75% of sporadic forms. RET mutations are found in 98% of hereditary MTC and in 55% of sporadic MTC (1). The most frequent somatic RET mutation occurs
Externí odkaz:
https://doaj.org/article/120685819d9a4b3abbc44e391fba82eb
Autor:
Istvan Petak, Maud Kamal, Anna Dirner, Ivan Bieche, Robert Doczi, Odette Mariani, Peter Filotas, Anne Salomon, Barbara Vodicska, Vincent Servois, Edit Varkondi, David Gentien, Dora Tihanyi, Patricia Tresca, Dora Lakatos, Nicolas Servant, Julia Deri, Pauline du Rusquec, Csilla Hegedus, Diana Bello Roufai, Richard Schwab, Celia Dupain, Istvan T. Valyi-Nagy, Christophe Le Tourneau
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
Abstract Precision oncology is currently based on pairing molecularly targeted agents (MTA) to predefined single driver genes or biomarkers. Each tumor harbors a combination of a large number of potential genetic alterations of multiple driver genes
Externí odkaz:
https://doaj.org/article/25368c6568c249e3961734d462c71641
Autor:
Célia Dupain, Julien Masliah‐Planchon, Céline Gu, Elodie Girard, Pierre Gestraud, Pauline Du Rusquec, Edith Borcoman, Diana Bello, Francesco Ricci, Ségolène Hescot, Marie‐Paule Sablin, Patricia Tresca, Alexandre deMoura, Delphine Loirat, Maxime Frelaut, Anne Vincent‐Salomon, Charlotte Lecerf, Céline Callens, Samantha Antonio, Coralie Franck, Odette Mariani, Ivan Bièche, Maud Kamal, Christophe Le Tourneau, Vincent Servois
Publikováno v:
Molecular Oncology, Vol 15, Iss 1, Pp 104-115 (2021)
High‐throughput molecular profiling of solid tumours using core needle biopsies (CNB) allows the identification of actionable molecular alterations, with around 70% success rate. Although several studies have demonstrated the utility of small biops
Externí odkaz:
https://doaj.org/article/fd5e3a2e632f4a30ae0bd88e27294874
Autor:
Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, Marc Ruivard, Léa Dousset, Laurianne Grignou, Dimitri Psimaras, Johan Pluvy, Gilles Quéré, Franck Grados, Fanny Duval, Frederic Bourdain, Gwenola Maigne, Julie Perrin, Benoit Godbert, Beatris Irina Taifas, Alexandra Forestier, Anne-Laure Voisin, Patricia Martin-Romano, Capucine Baldini, Aurélien Marabelle, Christophe Massard, Jérôme Honnorat, Olivier Lambotte, Jean-Marie Michot
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Background Paraneoplastic syndromes (PNS) are autoimmune disorders specifically associated with cancer. There are few data on anti-PD-1 or anti-PD-L1 immunotherapy in patients with a PNS. Our objective was to describe the outcome for patient
Externí odkaz:
https://doaj.org/article/ca72d3ba97984c078f0aec5f8467a55e
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Recently many therapeutic classes have emerged in advanced hormone receptor-positive breast cancer, which is the leading cause of cancer death in women. In absence of visceral crisis, treatment relies on endocrine therapy combined with cyclin depende
Externí odkaz:
https://doaj.org/article/8b1b051acf4145d58d96075668e7bba1
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Immunotherapy by chimeric antigen receptor (CAR)-modified T-cells has shown unprecedented clinical efficacy for hematological malignancies. Recently two CAR T-cell based therapeutics, Kymriah (Tisagenlecleucel) and Yescarta (Axicabtagene ciloleucel)
Externí odkaz:
https://doaj.org/article/b7d996b07b0e4774a4fa0733ef4033f6
Autor:
Ségolène Hescot, Véronique Debien, Julien Hadoux, Delphine Drui, Magalie Haissaguerre, Christelle de la Fouchardiere, Delphine Vezzosi, Christine Do Cao, Rossella Libé, Christophe Le Tourneau, Eric Baudin, Christophe Massard, Pauline du Rusquec
Publikováno v:
European Journal of Cancer.
Autor:
Ségolène Hescot, Julien Masliah-Planchon, Pauline du Rusquec, Célia Dupain, Maud Kamal, Vincent Servois, Ivan Bieche
Publikováno v:
European Thyroid Journal. 11
Autor:
Marie-Paule Sablin, Vincent Servois, Céline Gu, Edith Borcoman, Celia Dupain, Maud Kamal, Delphine Loirat, Elodie Girard, Ségolène Hescot, Diana Bello, Alexandre de Moura, Céline Callens, Charlotte Lecerf, Pierre Gestraud, Julien Masliah-Planchon, Maxime Frelaut, Odette Mariani, Samantha Antonio, Francesco Ricci, Pauline du Rusquec, Ivan Bièche, P. Tresca, Coralie Franck, Christophe Le Tourneau, Anne Vincent-Salomon
Publikováno v:
Molecular Oncology, Vol 15, Iss 1, Pp 104-115 (2021)
Molecular Oncology
Molecular Oncology
High‐throughput DNA analyses in cancers allow the detection of molecular abnormalities that can guide patients' treatment. The collection of a tumour DNA is mainly performed on a biopsy, an invasive procedure for the patients. Another less invasive
Autor:
Coraline Dubot, Christophe Le Tourneau, Maxime Frelaut, Grégoire Marret, Ivan Bièche, Delphine Loirat, Celia Dupain, Ségolène Hescot, Pauline du Rusquec, Edith Borcoman, Charlotte Lecerf, Maud Kamal, Marie-Paule Sablin, Diana Bello, P. Tresca, Francesco Ricci
Publikováno v:
JCO precision oncology. 5
Development of high-throughput technologies helped to decipher tumor genomic landscapes revealing actionable molecular alterations. We aimed to rank the level of evidence of recurrent actionable molecular alterations in head and neck squamous cell ca